[go: up one dir, main page]

FI882746L - Hybridprotein c och foerfarande foer dess framstaellning. - Google Patents

Hybridprotein c och foerfarande foer dess framstaellning. Download PDF

Info

Publication number
FI882746L
FI882746L FI882746A FI882746A FI882746L FI 882746 L FI882746 L FI 882746L FI 882746 A FI882746 A FI 882746A FI 882746 A FI882746 A FI 882746A FI 882746 L FI882746 L FI 882746L
Authority
FI
Finland
Prior art keywords
hybridprotein
foerfarande foer
och foerfarande
foer dess
dess framstaellning
Prior art date
Application number
FI882746A
Other languages
English (en)
Other versions
FI882746A0 (fi
FI882746A7 (fi
Inventor
Wakako Iwasaki
Mikiko Takahashi
Tamotsu Hashimoto
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of FI882746A0 publication Critical patent/FI882746A0/fi
Publication of FI882746L publication Critical patent/FI882746L/fi
Publication of FI882746A7 publication Critical patent/FI882746A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI882746A 1987-06-12 1988-06-09 Hybridiproteiini C ja menetelmä sen valmistamiseksi. FI882746A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14529387 1987-06-12

Publications (3)

Publication Number Publication Date
FI882746A0 FI882746A0 (fi) 1988-06-09
FI882746L true FI882746L (fi) 1988-12-13
FI882746A7 FI882746A7 (fi) 1988-12-13

Family

ID=15381791

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882746A FI882746A7 (fi) 1987-06-12 1988-06-09 Hybridiproteiini C ja menetelmä sen valmistamiseksi.

Country Status (7)

Country Link
EP (1) EP0296413A2 (fi)
JP (1) JP2799316B2 (fi)
KR (1) KR890000517A (fi)
AU (1) AU1756588A (fi)
DK (1) DK317288A (fi)
FI (1) FI882746A7 (fi)
PT (1) PT87688B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516650A (en) * 1985-06-27 1996-05-14 Zymogenetics, Inc. Production of activated protein C
JP2728240B2 (ja) * 1988-07-26 1998-03-18 ヘキスト薬品工業株式会社 ヒトプロテインｃ変異体及びその製造方法
US5298599A (en) * 1988-12-30 1994-03-29 Oklahoma Medical Research Foundation Expression and purification of recombinant soluble tissue factor
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
JP3153236B2 (ja) * 1989-12-22 2001-04-03 ザイモジェネティクス，インコーポレイティド 端が切り取られた軽鎖を有する組換えプロテインｃ
ATE163048T1 (de) * 1989-12-29 1998-02-15 Zymogenetics Inc Hybrides protein c
US5225537A (en) * 1989-12-29 1993-07-06 Zymogenetics, Inc. Methods for producing hybrid phospholipid-binding proteins
EP0521873B1 (en) * 1990-01-29 1999-06-02 Zymogenetics, Inc. Anticoagulant proteins
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
DE69735597T2 (de) * 1996-11-08 2006-12-21 Oklahoma Medical Research Foundation, Oklahoma Verwendung eines modifizierten protein-c
SE9701228D0 (sv) * 1997-04-03 1997-04-03 Bjoern Dahlbaeck Rekombinanta protein-C-och protein-S-varianter
US6747003B1 (en) 1997-10-23 2004-06-08 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6693075B1 (en) 1997-10-23 2004-02-17 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6017882A (en) * 1997-10-23 2000-01-25 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7247708B2 (en) 1997-10-23 2007-07-24 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6998122B1 (en) 1999-04-30 2006-02-14 Eli Lilly And Company Protein C derivatives
DE60108076T2 (de) 2000-02-02 2006-03-16 Eli Lilly And Co., Indianapolis Protein c derivate
ATE428445T1 (de) 2000-02-11 2009-05-15 Bayer Healthcare Llc Gerinnungsfaktor vii oder viia konjugate
WO2001059084A1 (en) 2000-02-11 2001-08-16 Eli Lilly And Company Protein c derivatives
US7812132B2 (en) 2000-04-28 2010-10-12 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US7220837B1 (en) 2000-04-28 2007-05-22 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US20030211094A1 (en) 2001-06-26 2003-11-13 Nelsestuen Gary L. High molecular weight derivatives of vitamin k-dependent polypeptides
DE60334983D1 (de) 2002-04-30 2010-12-30 Bayer Healthcare Llc Faktor vii oder faktor viia polypeptidvarianten
EP2085470B1 (en) 2003-03-20 2012-05-16 Bayer HealthCare LLC FVII or FVIIa variants
RU2373282C2 (ru) 2003-06-19 2009-11-20 Байер Хелткэр Ллк ВАРИАНТЫ ДОМЕНА GLA ФАКТОРА VII ИЛИ VIIa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
ATE93272T1 (de) * 1985-06-27 1993-09-15 Zymogenetics Inc Expression von protein c.

Also Published As

Publication number Publication date
KR890000517A (ko) 1989-03-15
JPS6485096A (en) 1989-03-30
FI882746A0 (fi) 1988-06-09
DK317288D0 (da) 1988-06-10
PT87688B (pt) 1992-09-30
AU1756588A (en) 1988-12-15
DK317288A (da) 1988-12-13
JP2799316B2 (ja) 1998-09-17
FI882746A7 (fi) 1988-12-13
EP0296413A2 (en) 1988-12-28
PT87688A (pt) 1988-07-01

Similar Documents

Publication Publication Date Title
FI880929L (fi) Destrukturerad staerkelse och foerfarande foer dess framstaellning.
FI883436A0 (fi) Vaetskebehaollare och dess framstaellningsfoerfarande.
FI882813A7 (fi) Pyrazolopyridinfoerening och foerfarande foer dess framstaellning.
FI884617L (fi) Isotonisk -3-fettsyrahaltig fettemulsion och dess anvaendning.
FI885599A7 (fi) Loestagningshjaelpmedel och dess anvaendning.
FI884749A7 (fi) Autogenisk tvaokammarblodtransfusionsanordning och foerfarande foer dess anvaendning.
FI885148A0 (fi) Siktkorg och foerfarande foer dess tillverkning.
FI881372L (fi) Katalytunderlag och foerfarande foer dess framstaellning.
FI884318L (fi) Imidazopyridinfoerening och foerfarande foer dess framstaellning.
FI884256L (fi) Livsmedelsfoerpackning och foerfarande foer dess framstaellning.
FI882746L (fi) Hybridprotein c och foerfarande foer dess framstaellning.
FI882245L (fi) Materialbana och foerfarande foer dess framstaellning.
FI883383L (fi) Hjaelpmedelskomposition foer goedslingsmedel och dess anvaendning.
FI880453L (fi) Narkosmedelkomposition och foerfarande foer dess anvaendning.
FI893269A0 (fi) Sprickor detekterande glasskiva och foerfarande foer dess framstaellning.
FI881339A7 (fi) Kompaktlysroer och foerfarande foer dess framstaellning.
FI882873L (fi) Tiofenderivat och foerfarande foer dess framstaellning.
FI881478A7 (fi) Behaollare och foerfarande foer dess framstaellning.
FI880543A0 (fi) Lyftstropp och foerfarande foer dess framstaellning.
FI873285A0 (fi) Fiberarmerat roerelement och foerfarande foer dess tillverkning.
FI882874L (fi) Tiofenderivat och foerfarande foer dess framstaellning.
FI884004L (fi) Benzofuranderivat och foerfarande foer dess framstaellning.
FI880875L (fi) Haorkosmetisk sammansaettning och dess framstaellningsfoerfarande.
FI870761L (fi) Filmaggregat och foerfarande foer dess framstaellning.
FI870757A0 (fi) Lyftstropp och foerfarande foer dess tillverkning.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: HOECHST JAPAN LIMITED